Gilead Suit Advances Alleging It Delayed Safer HIV Drugs

Gilead Sciences Inc. failed to exit a proposed class action alleging it delayed introducing safer HIV drugs, as a Missouri federal court said federal law ...


View article...


Top stories of the last 30 days